{"contract": "sm-investment-case-1", "found": true, "available": true, "as_of": "2026-09-11", "checked_on": "2026-09-18", "listing": {"uuid": "62392bd1-8921-4120-a935-b80f1ed83297", "symbol": "TMO", "name": "Thermo Fisher Scientific Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "business_type": "Operating company", "price": {"value": 609.82, "currency": "USD", "as_of": "2026-09-11", "basis": "Completed weekly quoted close; before dividends"}, "assessment": {"available": true, "rating": "Sell", "target_price": 178.73, "target_date": "2027-09-11", "price_change_to_target_pct": -70.69, "currency": "USD", "reviewed_on": "2026-09-16", "explanation": "The central target is 70.7% below the price, meeting the 25% downside requirement. That decline also exceeds or matches the stronger-case upside of 0.0%. This is a valuation view, not a finding that the business is poor.", "assumptions": [{"name": "Starting annual sales growth", "value": 6.69, "unit": "percent"}, {"name": "Long-term operating margin", "value": 17.48, "unit": "percent"}]}, "review": {"status": "Published assessment", "last_checked": "2026-09-18T01:41:51.509408+00:00", "next_scheduled": "2026-12-15", "published_at": "2026-09-16T15:45:52.087850+00:00", "environment": "live", "publication_url": "https://sharemaestro.com/investment-case/record/2102/"}, "business_view": {"headline": "A higher valuation comes with stronger profitability.", "summary": "Year-to-date profit has improved, but price has outpaced earnings.", "case_for": [{"headline": "Year-to-date profit has improved", "explanation": "Across 2 completed quarters since 2025-12-31, net income was 3,387.0m versus 3,124.0m in the matching prior-year periods (USD). Check whether the latest quarter changes that direction.", "evidence_url": "https://sharemaestro.com/investment-case/ticker/62392bd1-8921-4120-a935-b80f1ed83297/#ic-quarter-profit"}, {"headline": "The stock is leading its sector", "explanation": "Over one year, the stock changed +27.2% against +19.7% for Healthcare (XLV). The gap is +7.5 percentage points. These are price returns, before dividends.", "evidence_url": "https://sharemaestro.com/investment-case/ticker/62392bd1-8921-4120-a935-b80f1ed83297/#ic-market-price"}], "case_against": [{"headline": "Price has outpaced earnings", "explanation": "Over 1 year (2025-09-12 to 2026-09-11), price changed +27.2% and trailing EPS changed +8.9%. A wider gap changes the earnings multiple; it does not establish fair value.", "evidence_url": "https://sharemaestro.com/investment-case/ticker/62392bd1-8921-4120-a935-b80f1ed83297/#ic-earnings-horizons"}, {"headline": "The starting valuation is below the price", "explanation": "The central assumptions give $109.78 per share, -82.0% against the weekly close. This is a scenario to test, not an analyst price target.", "evidence_url": "https://sharemaestro.com/investment-case/ticker/62392bd1-8921-4120-a935-b80f1ed83297/#ic-valuation-grid"}]}, "watch_points": [], "financial_period": "2026-06-30", "next_results": "2026-10-28", "data_notes": ["Financial totals have been checked against their reporting periods. Only matching twelve-month figures are used; unsupported measures remain blank."], "canonical_url": "https://sharemaestro.com/investment-case/ticker/62392bd1-8921-4120-a935-b80f1ed83297/", "pdf_url": "https://sharemaestro.com/investment-case/ticker/62392bd1-8921-4120-a935-b80f1ed83297/download.pdf", "limitations": ["The published assessment stays fixed between governed reviews. Scenarios edited in the browser do not change it.", "Each financial period and price date is separate. Company coverage varies.", "Targets exclude dividends, fees and tax. A missing target is unavailable, not zero.", "Preview assessments are identified and do not establish a live performance record."], "disclaimer": "Automated model research, not personal investment advice. Targets depend on assumptions; returns are not guaranteed.", "revision": "d2ebc834e45a0e6cde0d4ffc061638588ce672ffa1cedd5cd3d2002c3cc297bb"}